EUVIMEDOpdag EUVIMED
Crossref

mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management

Fan Yang, Dongju Zhao iD, Meng Cheng, Yining Liu, Ziyao Chen, Jin Chang iD, Yan Dou iD

ACS Nano · 2023-08-22 · 17 (16) · 15724-15741

DOI: 10.1021/acsnano.3c03232 ↗

At a glance

Journal article in ACS Nano, published online on 2023-08-11. Written by Fan Yang and 6 co-authors. Institution: School of Life Sciences, Tianjin University, Tianjin 300072, P. R. China. Major MEDLINE topics: Microglia, Alzheimer Disease. Cited 64 times so far (Crossref); 62 references. Funded by: Natural Science Foundation of Tianjin City, National Natural Science Foundation of China, Tianjin Key Medical Discipline (Specialty) Construction Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metabolic reprogramming that senses brain homeostasis imbalances is necessary to drive detrimental microglial polarization, and specific targeting of this process contributes to the flexible control of pathological inflammatory responses in Alzheimer's disease (AD), displaying distinctive therapeutic benefits. Herein, glutathione-functionalized gold nanocages loaded with the immunosuppressant fingolimod hydrochloride are developed as brain-targeted and microglia-located immunometabolic reprogramming nanomodulators (GAF NPs) for AD management. By virtue of glutathione-mediated transport properties, this nanomodulator can cross the blood-brain barrier and localize to microglia in AD lesions. Through blocking Akt/mTOR/HIF-1α signaling pathways, GAF NPs not only promote the dominated metabolic shift from glycolysis to oxidative phosphorylation under immune activation but also inhibit transporter-mediated glucose overconsumption by microglia. Correlation analysis based on real-time bioenergetic assessment and 18F-labeled fluorodeoxyglucose (FDG) PET reveals that brain glucose utilization and metabolism restored by GAF NP treatment can serve as a sensitive and effective indicator for microglial M1 to M2 polarization switching, ultimately alleviating neuroinflammation and its derived neurodegeneration as well as ameliorating cognitive decline in AD mice. This work highlights a potential nanomedicine aimed at modifying mTOR-mediated immunometabolic reprogramming to halt energy deprivation-induced AD progression.

Subjects

MeSH terms (MEDLINE)

MicrogliaAlzheimer DiseaseMiceAnimalsTOR Serine-Threonine KinasesSignal TransductionGlucose

Author keywords

18F-FDG PETAkt/mTOR/HIF-1α signalingAlzheimer’s diseaseImmunometabolic reprogrammingbrain energy metabolismmicroglial polarizationnanomedicine

Substances

TOR Serine-Threonine KinasesGlucose

Authors and institutions

  • School of Life Sciences, Tianjin University, Tianjin 300072, P. R. China.
  • Department of Radiology and Tianjin Key Laboratory of Functional Imaging, Tianjin Medical University General Hospital, Tianjin 300052, P. R. China.

ORCID profiles: Dongju Zhao, Jin Chang, Yan Dou

Funding

  • Natural Science Foundation of Tianjin City
  • National Natural Science Foundation of China
  • Tianjin Key Medical Discipline (Specialty) Construction Project

Cite

APA

Yang, F., Zhao, D., Cheng, M., Liu, Y., Chen, Z., Chang, J., & Dou, Y. (2023). mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management. ACS Nano, 17(16), 15724-15741. https://doi.org/10.1021/acsnano.3c03232

Vancouver

Yang F, Zhao D, Cheng M, Liu Y, Chen Z, Chang J, et al. mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management. ACS Nano. 2023;17(16):15724-15741. doi:10.1021/acsnano.3c03232

BibTeX
@article{Yang2023,
  author = {Yang, Fan and Zhao, Dongju and Cheng, Meng and Liu, Yining and Chen, Ziyao and Chang, Jin and Dou, Yan},
  title = {mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {16},
  pages = {15724--15741},
  doi = {10.1021/acsnano.3c03232}
}
Start for free →